SXI Life Sciences
7.785,82
PKT
+6,91
PKT
+0,09
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.01.05 | Novartis Empfehlungsliste | Erste Bank | |
| 18.01.05 | Straumann Outperform | Credit Suisse First Boston | |
| 17.01.05 | Tecan (N) Neutral | Credit Suisse First Boston | |
| 17.01.05 | Basilea Pharmaceutica Outperform | Credit Suisse First Boston | |
| 17.01.05 | Sonova Outperform | Credit Suisse First Boston | |
| 13.01.05 | Novartis Buy | AG Edwards | |
| 12.01.05 | Novartis Hold | Smith Barney Citigroup | |
| 13.01.05 | Novartis Kaufen | Hamburger Sparkasse | |
| 11.01.05 | Novartis Sell | Banc of America Sec. | |
| 10.01.05 | Lonza Underperform | Goldman Sachs | |
| 11.01.05 | Novartis Empfehlungsliste | Erste Bank | |
| 04.01.05 | Novartis Buy | Deutsche Securities | |
| 18.01.05 | Novartis Outperform | Goldman Sachs |